Genetic factors underlying the risk of thalidomide-related neuropathy in patients with multiple myeloma.

D.C. Johnson, S.L. Corthals, B.A. Walker, F.M. Ross, W.M. Gregory, N.J. Dickens, H.M. Lokhorst, H. Goldschmidt, F.E. Davies, B.G.M. Durie, B. van Ness, J.A. Child, P. Sonneveld, G.J. Morgan

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)797-804
Number of pages8
JournalJournal of Clinical Oncology
Volume29
Issue number7
Publication statusPublished - 2011

Cite this